Evoke Pharma
EVOK
EVOK
21 hedge funds and large institutions have $9.64M invested in Evoke Pharma in 2018 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more ownership
Funds ownership: 0.13% → 0.13% (+0%)
Holders
21
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$120K | |
| 2 | +$111K | |
| 3 | +$32.9K | |
| 4 |
VF
Virtu Financial
New York
|
+$32.9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$19.7K |
Top Sellers
| 1 | -$62K | |
| 2 | -$32K | |
| 3 | -$26.5K | |
| 4 |
TSS
Two Sigma Securities
New York
|
-$853 |